Marker Therapeutics, Inc. (MRKR)
1.46
0.00 (0.00%)
USD |
NASDAQ |
May 01, 15:37
Marker Therapeutics Enterprise Value : 7.300M for April 30, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenaya Therapeutics, Inc. | 60.25M |
| Viridian Therapeutics, Inc. | 685.84M |
| ACADIA Pharmaceuticals, Inc. | 3.060B |
| Neurocrine Biosciences, Inc. | 12.21B |
| electroCore, Inc. | 50.42M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.703M |
| Revenue (Quarterly) | 1.103M |
| Total Expenses (Quarterly) | 2.807M |
| EPS Diluted (Quarterly) | -0.1022 |
| Profit Margin (Quarterly) | -154.4% |
| Earnings Yield | -62.29% |
| Normalized Earnings Yield | -62.29 |